Gene-Targeted Drug Shows Promise Against a Form of Pancreatic Cancer
TUESDAY, May 11, 2021 -- There may be new hope for patients with a subset of pancreatic cancers tied to certain genetic mutations, a new study finds.
The study involving 42 patients found that a " PARP inhibitor " drug called rucaparib (Rubraca), may...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | General Medicine | Genetics | Pancreas | Pancreatic Cancer | Study